![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/506 | (2006.01) |
A61P 3/06 | (2006.01) | ||
A61P 9/00 | (2006.01) |
(11) | Number of the document | 3102212 |
(13) | Kind of document | T |
(96) | European patent application number | 14705225.2 |
Date of filing the European patent application | 2014-02-05 | |
(97) | Date of publication of the European application | 2016-12-14 |
(45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
(46) | Date of publication of the claims translation | 2019-02-25 |
(86) | Number | PCT/NL2014/050068 |
Date | 2014-02-05 |
(87) | Number | WO 2015/119495 |
Date | 2015-08-13 |
(72) |
FORD, John, GB
ROUND, Patrick, GB
KASTELEIN, John, NL
KAWAGUCHI, Atsuhiro, JP
TOMIYASU, Koichi, JP
OKA, Kozo, JP
|
(73) |
NewAmsterdam Pharma B.V.,
Gooimeer 2 - 35, 1411 DC, Naarden,
NL
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Cholesterilo esterio pernešimo baltymo (CETP) inhibitorius ir farmacinės kompozicijos, apimančios minėtą inhibitorių, skirtos panaudoti širdies ir kraujagyslių ligų gydymui arba prevencijai |
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES |
Payment date | Validity (years) | Amount | |
2025-01-21 | 12 | 289.00 EUR |
2026-02-05 |